These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 21943049)
1. Dupuytren's: a systems biology disease. Rehman S; Goodacre R; Day PJ; Bayat A; Westerhoff HV Arthritis Res Ther; 2011; 13(5):238. PubMed ID: 21943049 [TBL] [Abstract][Full Text] [Related]
2. Microarray analysis of Dupuytren's disease cells: the profibrogenic role of the TGF-β inducible p38 MAPK pathway. Ratkaj I; Bujak M; Jurišić D; Baus Lončar M; Bendelja K; Pavelić K; Kraljević Pavelić S Cell Physiol Biochem; 2012; 30(4):927-42. PubMed ID: 22965824 [TBL] [Abstract][Full Text] [Related]
3. Dupuytren's disease therapy: targeting the vicious cycle of myofibroblasts? Musumeci M; Vadalà G; Russo F; Pelacchi F; Lanotte A; Denaro V Expert Opin Ther Targets; 2015; 19(12):1677-87. PubMed ID: 26690790 [TBL] [Abstract][Full Text] [Related]
4. Developing an animal model of Dupuytren's disease by orthotopic transplantation of human fibroblasts into athymic rat. Satish L; Palmer B; Liu F; Papatheodorou L; Rigatti L; Baratz ME; Kathju S BMC Musculoskelet Disord; 2015 Jun; 16():138. PubMed ID: 26049932 [TBL] [Abstract][Full Text] [Related]
6. Expression of a novel gene, MafB, in Dupuytren's disease. Lee LC; Zhang AY; Chong AK; Pham H; Longaker MT; Chang J J Hand Surg Am; 2006 Feb; 31(2):211-8. PubMed ID: 16473681 [TBL] [Abstract][Full Text] [Related]
7. Genome-wide analysis using exon arrays demonstrates an important role for expression of extra-cellular matrix, fibrotic control and tissue remodelling genes in Dupuytren's disease. Forrester HB; Temple-Smith P; Ham S; de Kretser D; Southwick G; Sprung CN PLoS One; 2013; 8(3):e59056. PubMed ID: 23554969 [TBL] [Abstract][Full Text] [Related]
8. Whole genome and global expression profiling of Dupuytren's disease: systematic review of current findings and future perspectives. Shih B; Watson S; Bayat A Ann Rheum Dis; 2012 Sep; 71(9):1440-7. PubMed ID: 22772327 [TBL] [Abstract][Full Text] [Related]
9. Integrative genomic and transcriptomic analysis of genetic markers in Dupuytren's disease. Jung J; Kim GW; Lee B; Joo JWJ; Jang W BMC Med Genomics; 2019 Jul; 12(Suppl 5):98. PubMed ID: 31296227 [TBL] [Abstract][Full Text] [Related]
10. Identification of histological patterns in clinically affected and unaffected palm regions in dupuytren's disease. Alfonso-Rodríguez CA; Garzón I; Garrido-Gómez J; Oliveira AC; Martín-Piedra MÁ; Scionti G; Carriel V; Hernández-Cortés P; Campos A; Alaminos M PLoS One; 2014; 9(11):e112457. PubMed ID: 25379672 [TBL] [Abstract][Full Text] [Related]
11. Dupuytren's disease: a localised and accessible human fibrotic disorder. Layton TB; Williams L; Nanchahal J Trends Mol Med; 2023 Mar; 29(3):218-227. PubMed ID: 36566101 [TBL] [Abstract][Full Text] [Related]
12. An integrated proteomics approach for studying the molecular pathogenesis of Dupuytren's disease. Kraljevic Pavelic S; Sedic M; Hock K; Vucinic S; Jurisic D; Gehrig P; Scott M; Schlapbach R; Cacev T; Kapitanovic S; Pavelic K J Pathol; 2009 Mar; 217(4):524-33. PubMed ID: 19089850 [TBL] [Abstract][Full Text] [Related]
13. An insight into Dupuytren's contracture. Murrell GA Ann R Coll Surg Engl; 1992 May; 74(3):156-60; discussion 161. PubMed ID: 1616255 [TBL] [Abstract][Full Text] [Related]
14. Molecular phenotypic descriptors of Dupuytren's disease defined using informatics analysis of the transcriptome. Rehman S; Salway F; Stanley JK; Ollier WE; Day P; Bayat A J Hand Surg Am; 2008 Mar; 33(3):359-72. PubMed ID: 18343292 [TBL] [Abstract][Full Text] [Related]
15. Illuminating the effect of beneficial blue light and ROS-modulating enzymes in Dupuytren's disease. Jaekel C; Thelen S; Oezel L; Wohltmann MH; Wille J; Windolf J; Grotheer V PLoS One; 2021; 16(7):e0253777. PubMed ID: 34270583 [TBL] [Abstract][Full Text] [Related]
16. Functional genomics in identification of drug targets in Dupuytren's contracture. Sedic M; Jurisic D; Stanec Z; Hock K; Pavelic K; Kraljevic Pavelic S Front Biosci (Landmark Ed); 2010 Jan; 15(1):57-64. PubMed ID: 20036806 [TBL] [Abstract][Full Text] [Related]
17. Recent advances in the understanding of Dupuytren's disease. Layton T; Nanchahal J F1000Res; 2019; 8():. PubMed ID: 30854193 [TBL] [Abstract][Full Text] [Related]
18. Involvement of pro-inflammatory cytokines and growth factors in the pathogenesis of Dupuytren's contracture: a novel target for a possible future therapeutic strategy? Bianchi E; Taurone S; Bardella L; Signore A; Pompili E; Sessa V; Chiappetta C; Fumagalli L; Di Gioia C; Pastore FS; Scarpa S; Artico M Clin Sci (Lond); 2015 Oct; 129(8):711-20. PubMed ID: 26201022 [TBL] [Abstract][Full Text] [Related]